Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing

Iris Böselt1, Despoina Tramma, Serafia Kalamitsou

  • 1Molecular Biochemistry, Institute of Biochemistry, Medical Faculty, University of Leipzig, Leipzig, Germany.

Abstract

Insights

X-linked nephrogenic diabetes insipidus (NDI) results from AVPR2 gene mutations. Novel mutations identified cause receptor dysfunction by impairing folding and cell surface expression, leading to NDI in patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Endocrinology

Background:

  • X-linked nephrogenic diabetes insipidus (NDI) is a rare disorder characterized by polyuria.
  • It is caused by inactivating mutations in the arginine vasopressin receptor Type 2 (AVPR2) gene.

Purpose of the Study:

  • To identify and characterize novel mutations in the AVPR2 gene in NDI patients.
  • To elucidate the molecular mechanisms underlying AVPR2 receptor dysfunction.

Main Methods:

  • Mutational analysis of the AVPR2 gene in NDI patients from six families.
  • In vitro functional and immunological characterization of novel AVPR2 mutants using COS-7 cells.

Main Results:

  • Four novel (A89P, G107R, Q174R, W208X) and three recurrent (V277A, R337X, ΔR247-G250) AVPR2 mutations were identified.
  • Missense mutations (A89P, G107R, Q174R, V277A) impaired receptor cell surface expression and function, likely due to misfolding and intracellular retention.
  • A deletion in the third intracellular loop (ΔR247-G250) did not affect receptor function in vitro.

Conclusions:

  • Identified AVPR2 mutations are responsible for causing NDI in affected individuals.
  • Specific residues are critical for AVPR2 folding, trafficking, and function.

Related Concept Videos

Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...